Cargando…

Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada

BACKGROUND: People who use illicit drugs (PWUD) are commonly diagnosed with major depressive disorder (MDD). However, little is known about whether PWUD living with MDD experience additional barriers to accessing health services compared to those without MDD. We sought to identify whether MDD sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaulieu, Tara, Ti, Lianping, Milloy, M.-J., Nosova, Ekaterina, Wood, Evan, Hayashi, Kanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775557/
https://www.ncbi.nlm.nih.gov/pubmed/29351757
http://dx.doi.org/10.1186/s13011-018-0142-9
_version_ 1783293934218248192
author Beaulieu, Tara
Ti, Lianping
Milloy, M.-J.
Nosova, Ekaterina
Wood, Evan
Hayashi, Kanna
author_facet Beaulieu, Tara
Ti, Lianping
Milloy, M.-J.
Nosova, Ekaterina
Wood, Evan
Hayashi, Kanna
author_sort Beaulieu, Tara
collection PubMed
description BACKGROUND: People who use illicit drugs (PWUD) are commonly diagnosed with major depressive disorder (MDD). However, little is known about whether PWUD living with MDD experience additional barriers to accessing health services compared to those without MDD. We sought to identify whether MDD symptoms were associated with perceived barriers to accessing health services among people who use illicit drugs (PWUD) in Vancouver, Canada. METHODS: Data were collected through prospective cohorts of PWUD in Vancouver, Canada between 2005 and 2016. Using multiple logistic regression, we examined the relationship between MDD symptoms, defined as a Centre for Epidemiologic Studies Depression (CES-D) scale total score of ≥16, and barriers to access health services. We also used descriptive statistics to examine common barriers among participants who reported any barriers. RESULTS: Among a total of 1529 PWUD, including 521 (34.1%) females, 415 (27.1%) reported barriers to accessing health services, and 956 (62.5%) reported MDD symptoms at baseline. In multiple logistic regression analyses, after adjusting for a range of potential confounders, MDD symptoms (adjusted odds ratio [AOR] = 1.40; 95% confidence interval [CI]: 1.03–1.92) were positively and significantly associated with barriers to accessing health services. Among those who reported MDD symptoms and barriers to access, commonly reported barriers included: long wait lists/times (38.1%); and treated poorly by health care professionals (30.0%). CONCLUSION: These findings show that the likelihood of experiencing barriers to accessing health services was higher among PWUD with MDD symptoms compared to their counterparts. Policies and interventions tailored to address these barriers are urgently needed for this subpopulation of PWUD.
format Online
Article
Text
id pubmed-5775557
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57755572018-01-31 Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada Beaulieu, Tara Ti, Lianping Milloy, M.-J. Nosova, Ekaterina Wood, Evan Hayashi, Kanna Subst Abuse Treat Prev Policy Research BACKGROUND: People who use illicit drugs (PWUD) are commonly diagnosed with major depressive disorder (MDD). However, little is known about whether PWUD living with MDD experience additional barriers to accessing health services compared to those without MDD. We sought to identify whether MDD symptoms were associated with perceived barriers to accessing health services among people who use illicit drugs (PWUD) in Vancouver, Canada. METHODS: Data were collected through prospective cohorts of PWUD in Vancouver, Canada between 2005 and 2016. Using multiple logistic regression, we examined the relationship between MDD symptoms, defined as a Centre for Epidemiologic Studies Depression (CES-D) scale total score of ≥16, and barriers to access health services. We also used descriptive statistics to examine common barriers among participants who reported any barriers. RESULTS: Among a total of 1529 PWUD, including 521 (34.1%) females, 415 (27.1%) reported barriers to accessing health services, and 956 (62.5%) reported MDD symptoms at baseline. In multiple logistic regression analyses, after adjusting for a range of potential confounders, MDD symptoms (adjusted odds ratio [AOR] = 1.40; 95% confidence interval [CI]: 1.03–1.92) were positively and significantly associated with barriers to accessing health services. Among those who reported MDD symptoms and barriers to access, commonly reported barriers included: long wait lists/times (38.1%); and treated poorly by health care professionals (30.0%). CONCLUSION: These findings show that the likelihood of experiencing barriers to accessing health services was higher among PWUD with MDD symptoms compared to their counterparts. Policies and interventions tailored to address these barriers are urgently needed for this subpopulation of PWUD. BioMed Central 2018-01-19 /pmc/articles/PMC5775557/ /pubmed/29351757 http://dx.doi.org/10.1186/s13011-018-0142-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Beaulieu, Tara
Ti, Lianping
Milloy, M.-J.
Nosova, Ekaterina
Wood, Evan
Hayashi, Kanna
Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title_full Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title_fullStr Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title_full_unstemmed Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title_short Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada
title_sort major depressive disorder and access to health services among people who use illicit drugs in vancouver, canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775557/
https://www.ncbi.nlm.nih.gov/pubmed/29351757
http://dx.doi.org/10.1186/s13011-018-0142-9
work_keys_str_mv AT beaulieutara majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada
AT tilianping majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada
AT milloymj majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada
AT nosovaekaterina majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada
AT woodevan majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada
AT hayashikanna majordepressivedisorderandaccesstohealthservicesamongpeoplewhouseillicitdrugsinvancouvercanada